Skip to main content
. 2023 Dec 16;12(24):4500. doi: 10.3390/foods12244500

Table 1.

Overview of supervised models generated for Trial 1.

Model Number Type (with Details of Pre-Processing Applied) R2 Q2
M3 PLS-DA (with SNV; par scaling) 0.926 0.914
M4 PLS-DA (with SNV, 1st D, SG, and par scaling) 0.832 0.882
M5 PLS-DA (with SNV, 2nd D, SG, and par scaling) 0.796 0.888
M6 PLS-DA (with 1st D, SG, SNV, and par scaling) 0.805 0.88
M7 PLS-DA (with 2nd D, SG, SNV, and par scaling) 0.776 0.874
M14 PLS-DA (no processing; par scaling) 0.991 0.877
M8 OPLS-DA (with SNV; par scaling) 0.926 0.915
M9 OPLS-DA (with SNV, 1st D, SG, and par scaling) 0.736 0.865
M10 OPLS-DA (with SNV, 2nd D, SG, and par scaling) 0.779 0.883
M11 OPLS-DA (1st D, SG, SNV, and par scaling) 0.806 0.882
M12 OPLS-DA (2nd D, SG, SNV, and par scaling) 0.757 0.882
M13 OPLS-DA (no processing; par scaling) 0.982 0.8